Recruiting Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL) NCT05833724 Conditions Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more Locations Chang Gung Memorial Hospital, Kaohsiung — Kaohsiung City, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City, Taiwan Far eastern memorial hospital — New Taipei City, Taiwan Taichung Veterans General Hospital — Taichung, Taiwan View more locations Show fewer locations Loading locations... View Trial Details
Completed Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy NCT02464228 Conditions Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more Locations Stanford University Medical Center — Palo Alto, California, United States Yale University, Yale Cancer Center — New Haven, Connecticut, United States H. Lee Moffitt Cancer Center & Research Institute, Inc. — Tampa, Florida, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma NCT03356678 Conditions Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more Locations Samsung Medical Center — Seoul, Seoul, Korea, Republic of, South Korea 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea — Seoul, South Korea View Trial Details
